Nektar Therapeutics Inc (NKTR)

22.25 -0.86  -3.74% NASDAQ Dec 10, 14:46 Delayed 2m USD

Nektar Therapeutics Revenue (TTM):

120.58M for Sept. 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Revenue (TTM) Chart

Export Data
Save Image
Print Image

Historical Revenue (TTM) Data

View and export this data going back to 1994. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2019 120.58M
June 30, 2019 119.12M
March 31, 2019 1.184B
Dec. 31, 2018 1.193B
Sept. 30, 2018 1.249B
June 30, 2018 1.374B
March 31, 2018 321.00M
Dec. 31, 2017 307.71M
Sept. 30, 2017 249.70M
June 30, 2017 133.10M
March 31, 2017 131.28M
Dec. 31, 2016 165.44M
Sept. 30, 2016 167.36M
June 30, 2016 190.97M
March 31, 2016 180.86M
Dec. 31, 2015 230.78M
Sept. 30, 2015 210.97M
June 30, 2015 283.88M
March 31, 2015 289.74M
Dec. 31, 2014 200.71M
Sept. 30, 2014 212.30M
June 30, 2014 140.34M
March 31, 2014 145.69M
Dec. 31, 2013 148.92M
Sept. 30, 2013 138.92M
   
June 30, 2013 96.42M
March 31, 2013 86.25M
Dec. 31, 2012 81.19M
Sept. 30, 2012 75.83M
June 30, 2012 84.48M
March 31, 2012 78.13M
Dec. 31, 2011 71.48M
Sept. 30, 2011 101.01M
June 30, 2011 111.87M
March 31, 2011 137.10M
Dec. 31, 2010 159.04M
Sept. 30, 2010 152.73M
June 30, 2010 125.03M
March 31, 2010 95.46M
Dec. 31, 2009 71.93M
Sept. 30, 2009 61.28M
June 30, 2009 72.49M
March 31, 2009 79.90M
Dec. 31, 2008 90.18M
Sept. 30, 2008 127.60M
June 30, 2008 162.49M
March 31, 2008 208.00M
Dec. 31, 2007 273.03M
Sept. 30, 2007 277.16M
June 30, 2007 279.47M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Advertisement

Revenue (TTM) Benchmarks

Benchmarks
Bristol-Myers Squibb Co 24.17B
Lipocine Inc --
Johnson & Johnson 81.71B

Revenue (TTM) Range, Past 5 Years

Minimum 119.12M Jun 2019
Maximum 1.374B Jun 2018
Average 415.16M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.